Evidence map›Paper›PMID 38610637›Full record

ArticleJournal of clinical medicine2024

Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports.

Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, Luigi Francesco Iannone, Silvia Bianchi, Anna Poggesi, Mario Bengala, Nicola Biagio Mercuri, Francesco De Cesaris

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Maria AlbaneseHeadache Center, Neurology Unit, Tor Vergata University Hospital, 00133 Rome, Italy.ORCID 0000-0002-5113-2017
Francesca PesciniStroke Unit, Emergency Department, AOU Careggi, 50134 Florence, Italy.ORCID 0000-0003-4565-5601
Chiara Di BonaventuraDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
Luigi Francesco IannoneSection of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, 50121 Florence, Italy.ORCID 0000-0003-3598-0195
Silvia BianchiDepartment of Medical Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.
Anna PoggesiStroke Unit, Emergency Department, AOU Careggi, 50134 Florence, Italy.ORCID 0000-0002-8694-0129
Mario BengalaTor Vergata University Hospital, Medical Genetics Unit, 00133 Rome, Italy.
Nicola Biagio MercuriHeadache Center, Neurology Unit, Tor Vergata University Hospital, 00133 Rome, Italy.ORCID 0000-0001-6700-7491
Francesco De CesarisHeadache Center and Clinical Pharmacology Unit, Careggi University Hospital, 50134 Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · ITUniversity of Rome Tor Vergata · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of cerebral small vessel disease, caused by a mutation in the

Indexed as

CADASILCGRPerenumabmigraineNOTCH3

Identifiers

PMID38610637
PMCPMC11012730
OpenAlexW4393142629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.